Gary E. DeLander

2.3k total citations · 1 hit paper
34 papers, 1.9k citations indexed

About

Gary E. DeLander is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Gary E. DeLander has authored 34 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 14 papers in Cellular and Molecular Neuroscience and 10 papers in Molecular Biology. Recurrent topics in Gary E. DeLander's work include Pain Mechanisms and Treatments (19 papers), Neuropeptides and Animal Physiology (11 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). Gary E. DeLander is often cited by papers focused on Pain Mechanisms and Treatments (19 papers), Neuropeptides and Animal Physiology (11 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). Gary E. DeLander collaborates with scholars based in United States, Sweden and Switzerland. Gary E. DeLander's co-authors include Gary J. Keil, Brenda L. Gleason, Amanda Bain, Gerald E. Meyer, Cindy D. Stowe, Victoria F. Roche, Diane E. Beck, Evan T. Robinson, Cecilia M. Plaza and Robert B. Supernaw and has published in prestigious journals such as Pain, Neuroscience and Journal of Medicinal Chemistry.

In The Last Decade

Gary E. DeLander

34 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Center for the Advancement of Pharmacy Education 2013 Educational Outcomes

2013 786 citations Gary E. DeLander et al. American Journal of Pharmaceutical Education profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary E. DeLander United States	22	627	610	535	535	399	34	1.9k
Manuel Gurpegui Spain	29	429 0.7×	224 0.4×	182 0.3×	133 0.2×	244 0.6×	77	2.2k
Jonathan Chick United Kingdom	29	151 0.2×	289 0.5×	183 0.3×	488 0.9×	607 1.5×	102	3.4k
Daniel E. Falk United States	28	430 0.7×	284 0.5×	252 0.5×	715 1.3×	422 1.1×	46	3.0k
Charles E. Yesalis United States	27	136 0.2×	260 0.4×	406 0.8×	173 0.3×	114 0.3×	64	2.8k
James W. McAuley United States	25	148 0.2×	330 0.5×	103 0.2×	216 0.4×	198 0.5×	61	1.7k
Maria Inês Rodrigues Lobato Brazil	26	171 0.3×	102 0.2×	213 0.4×	205 0.4×	93 0.2×	100	1.9k
Bridgette E. Garrett United States	23	1.1k 1.8×	374 0.6×	371 0.7×	313 0.6×	239 0.6×	32	2.2k
Jane Pei‐Chen Chang Taiwan	26	333 0.5×	279 0.5×	177 0.3×	86 0.2×	167 0.4×	98	2.3k
Gemma‐Claire Ali United Kingdom	8	366 0.6×	232 0.4×	182 0.3×	44 0.1×	339 0.8×	14	1.8k
Margaret Rukstalis United States	29	864 1.4×	779 1.3×	676 1.3×	732 1.4×	256 0.6×	60	2.9k

Countries citing papers authored by Gary E. DeLander

Since Specialization

Citations

This map shows the geographic impact of Gary E. DeLander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary E. DeLander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary E. DeLander more than expected).

Fields of papers citing papers by Gary E. DeLander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary E. DeLander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary E. DeLander. The network helps show where Gary E. DeLander may publish in the future.

Co-authorship network of co-authors of Gary E. DeLander

This figure shows the co-authorship network connecting the top 25 collaborators of Gary E. DeLander. A scholar is included among the top collaborators of Gary E. DeLander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary E. DeLander. Gary E. DeLander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

DeLander, Gary E.. (2017). Lessons From a Recovering Department Chair. American Journal of Pharmaceutical Education. 81(3). 43–43. 5 indexed citations

McKenzie, Glenise, et al.. (2016). Falls prevention education: Interprofessional training to enhance collaborative practice. Gerontology & Geriatrics Education. 38(2). 232–243. 26 indexed citations

Adams, Alex J., Gary E. DeLander, George E. MacKinnon, et al.. (2013). Report of the AACP Task Force on Patient-Centered Medical Homes and Accountable Care Organizations. American Journal of Pharmaceutical Education. 77(7). 142–142. 15 indexed citations

Brazeau, Gayle A., Susan M. Meyer, Edward M. Bednarczyk, et al.. (2009). Preparing Pharmacy Graduates for Traditional and Emerging Career Opportunities. American Journal of Pharmaceutical Education. 73(8). 157–157. 47 indexed citations

Wu, Weiping, Jing‐Xia Hao, Linda Halldner, et al.. (2004). Increased nociceptive response in mice lacking the adenosine A1 receptor. Pain. 113(3). 395–404. 105 indexed citations

Schulte, Gunnar, Brita Robertson, Bertil B. Fredholm, et al.. (2003). Distribution of antinociceptive adenosine a1 receptors in the spinal cord dorsal horn, and relationship to primary afferents and neuronal subpopulations. Neuroscience. 121(4). 907–916. 61 indexed citations

DeLander, Gary E., et al.. (1997). Temporal changes in spinal cord expression of mRNA for substance P, dynorphin and enkephalin in a model of chronic pain. Acta Physiologica Scandinavica. 161(4). 509–516. 19 indexed citations

DeLander, Gary E., et al.. (1997). Spinal expression of mRNA for immediate early genes in a model of chronic pain. Acta Physiologica Scandinavica. 161(4). 517–525. 21 indexed citations

Keil, Gary J. & Gary E. DeLander. (1996). Altered sensory behaviors in mice following manipulation of endogenous spinal adenosine neurotransmission. European Journal of Pharmacology. 312(1). 7–14. 28 indexed citations

10.

Arttamangkul, Seksiri, Thomas F. Murray, Gary E. DeLander, & Jane V. Aldrich. (1995). Synthesis and Opioid Activity of Conformationally Constrained Dynorphin A Analogs. 1. Conformational Constraint in the "Message" Sequence. Journal of Medicinal Chemistry. 38(13). 2410–2417. 27 indexed citations

11.

Heidt, Martin, et al.. (1992). Effect of modification of the basic residues of dynorphin A-(1-13) amide on opioid receptor selectivity and opioid activity. Journal of Medicinal Chemistry. 35(23). 4330–4333. 29 indexed citations

12.

Keil, Gary J. & Gary E. DeLander. (1992). Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase-, inhibitor. Life Sciences. 51(19). PL171–PL176. 55 indexed citations

13.

Choi, Hee Kyoung, et al.. (1992). N-Terminal alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are highly selective for .kappa.-opioid receptors. Journal of Medicinal Chemistry. 35(24). 4638–4639. 23 indexed citations

14.

Murray, Thomas F., et al.. (1992). Synthesis and opioid activity of 2–substituted dynorphin A‐(1‐13) amide analogues¹. International journal of peptide & protein research. 40(2). 89–96. 14 indexed citations

15.

DeLander, Gary E., et al.. (1991). Descending systems activated by morphine (ICV) inhibit kainic acid (IT)-induced behavior. Pharmacology Biochemistry and Behavior. 39(1). 155–159. 5 indexed citations

16.

DeLander, Gary E., et al.. (1989). In vivo characterization of phencyclidine/σ agonist-mediated inhibition of nociception. European Journal of Pharmacology. 159(2). 149–156. 16 indexed citations

17.

DeLander, Gary E., et al.. (1988). Behavior induced by putative nociceptive neurotransmitters is inhibited by adenosine or adenosine analogs coadministered intrathecally.. Journal of Pharmacology and Experimental Therapeutics. 246(2). 565–570. 42 indexed citations

18.

DeLander, Gary E., et al.. (1987). Involvement of A2 adenosine receptors in spinal mechanisms of antinociception. European Journal of Pharmacology. 139(2). 215–223. 57 indexed citations

19.

DeLander, Gary E., et al.. (1987). Interdependence of spinal adenosinergic, serotonergic and noradrenergic systems mediating antinociception. Neuropharmacology. 26(12). 1791–1794. 41 indexed citations

20.

DeLander, Gary E., et al.. (1986). Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine.. Journal of Pharmacology and Experimental Therapeutics. 239(1). 88–93. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact